Hematology and Oncology

Home Hematology and Oncology
For stable warfarin-treated patients

Extended INR Test Intervals Safe for Warfarin-Treated Patients

Similar number of out-of-range next INR values for patients with, without extended testing interval
Lung cancer incidence is higher among young women than young men

Lung Cancer Incidence Higher for Young Women Than Young Men

Crossover in sex-specific rates among U.S. non-Hispanic whites born since 1965
Providers engaging parents hesitant about human papillomavirus vaccination and addressing their concerns can lead to same-day vaccinations

Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates

More adolescents receive HPV vaccination same day with physician engagement versus acquiescence
Fewer men are being screened for

From 2008 to 2014, Prostate Cancer Testing, Treatment Down

Sharpest decrease seen in privately insured men after 2011

CDC: No Change in Level of Uninsured in U.S. in 2017

Five percent of children uninsured in 2017, 41.3 and 55.0 percent had public and private coverage
For patients with colorectal cancer after curative surgery

Surveillance Frequency Doesn’t Cut Mortality in Colorectal Cancer

And, intensity of imaging surveillance not linked to time to detection of colorectal cancer recurrence
For patients with active cancer and venous thromboembolism (VTE)

Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure
Breath analysis shows potential for noninvasive diagnosis of esophagogastric cancer

Breath Test Shows Promise for Diagnosis of Esophagogastric CA

Good diagnostic accuracy with area under the curve of 0.85, sensitivity and specificity of 80, 81 percent
For patients undergoing resection of colorectal liver metastases

V600E BRAF Mutation Tied to Worse Survival in CRC Liver Mets

Worse overall, disease-free survival with V600E BRAF versus KRAS mutation in colorectal liver metastases